Great gains on 500mg fin and 1000mg min everyday
    Satire 6/18/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this satirical post, the primary subjects mentioned are
    💊 Finasteride (oral) 500mg 1x daily
    💧 Minoxidil (topical) 1000mg 1x daily
    the tone is humorous with exaggerated growth results.

    Other terms

    The conversation humorously discusses exaggerated hair growth results using 500mg finasteride and 1000mg minoxidil daily, with side effects including a bloody nose and lowered libido. It also jokes about microneedling, hair transplants, and elephants, suggesting the post is satirical.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Functional Hair Follicle Regeneration: An Updated Review

      research Functional hair follicle regeneration: an updated review

      42 citations , February 2021 in “Signal Transduction and Targeted Therapy”
      This review discusses potential cell sources and bioengineering strategies for regenerating hair follicles with functional cycling, reporting no new results.
      Status of Research on the Development and Regeneration of Hair Follicles

      research Status of research on the development and regeneration of hair follicles

      November 2023 in “International Journal of Medical Sciences”
      This review examines the mechanisms of hair follicle development and regeneration, discussing current hair loss treatments and emerging therapies like low-level laser therapy and stem cell therapy, which the authors suggest show promise in managing hair loss.
      Guidelines Based Management of Androgenetic Alopecia

      research Guidelines based management of androgenetic alopecia

      January 2014 in “Cosmoderma”
      This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.
      Alopecia: Updated Management

      research Alopecia: Updated management

      June 2024 in “Bangladesh Journal of Medicine”
      This study offers a comprehensive overview of alopecia, detailing its various types, diagnostic approaches, and treatment options, including updated medical and procedural interventions such as Tofacitinib, PRP therapy, and microneedling, among others.
      Androgenetic Alopecia: An Update

      research Androgenetic alopecia: An update

      July 2023 in “JAAD International”
      This study describes androgenetic alopecia as a common non-scarring hair loss condition primarily influenced by genetic factors and androgen sensitivity, notably impacting psychosocial well-being, especially in females and younger males seeking treatment.